{"id":"13c-ro7049389","_chembl":null,"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T04:30:38.929Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123047,"model":"claude-sonnet-4-5-20250929"},"description":"[13C] RO7049389 is a carbon-13 labeled investigational compound developed by Hoffmann-La Roche currently in Phase 1 clinical trials. As a radiolabeled tracer molecule, it is likely being studied to understand drug metabolism, pharmacokinetics, or target engagement in early-stage clinical research.","indications":{"approved":[{"status":"investigational","condition":"Unknown - Phase 1 study","patientPopulation":"Likely healthy volunteers or patients in early-phase trial"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"[13C] RO7049389","genericName":"[13C] RO7049389","companyName":"Hoffmann-La Roche","companyId":"roche","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}